Stay updated with breaking news from Equity Method. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MorphoSys AG reports results for the first quarter of 2024. "The proposed acquisition by Novartis is advancing steadily, and we continue to anticipate its closure in the first half of 2024. The acceptance period for the acquisition is currently...
Significant operational and clinical progress in 2023 and early 2024 with maturation of Internal Programs,1 launch of two new Founded Entities,2 including a $100 million Series A financing for...
First Quarter 2024 Highlights Versus Prior Year Net Sales of $810 million, down 1% as reported and in constant currency Gross Margin of 48.0%, an increase of 800 basis points; Adjusted Gross...
Fourth Quarter and Full-Year Net Sales and Earnings Per Share Exceed Guidance Board of Directors Authorizes New Share Repurchase Program COLUMBUS, Ohio,...
ATLANTA, Feb. 15, 2024 /PRNewswire/ -- Southern Company today reported fourth-quarter earnings of $855 million, or 78 cents per share, in 2023 compared with a loss of $87 million, or 8 cents per...